Adjuvant gemcitabine in case of carcinoma of pancreas. A case report
Medical Channel. 2006; 12 (3): 57-58
em Inglês
| IMEMR
| ID: emr-79052
ABSTRACT
This report describes a case of a 53 year old man who presented with a diagnosis of carcinoma head of pancreas, and initially underwent surgery. Since carcinoma of pancreas has a high recurrence rate even after surgery, the patient was offered Gemcitabine [1000mg/m2, weekly for 7 weeks, then 1 week of rest followed by once weekly for 3 weeks, then rest week every 4 weeks]. He received 16 doses of gemcitabine. There was absolutely no grade 3 or 4 toxicity nor any delays, reductions or omission of doses. Post treatment CT scans showed no evidence of recurrence and patient is in good health 15 months post chemotherapy
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Tomografia Computadorizada por Raios X
/
Quimioterapia Adjuvante
/
Desoxicitidina
Tipo de estudo:
Relato de Casos
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Med. Channel
Ano de publicação:
2006
Similares
MEDLINE
...
LILACS
LIS